$2.25 Billion is the total value of NEA Management Company, LLC's 43 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 14.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TSRO | Buy | TESARO INC | $595,431,000 | -30.1% | 10,420,555 | +1.4% | 26.49% | -24.9% |
| CRSP | Buy | CRISPR THERAPEUTICS AGnamen akt | $159,275,000 | +110.6% | 3,484,464 | +8.2% | 7.08% | +126.1% |
| ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCadr | $149,725,000 | +86.4% | 13,332,611 | +10.9% | 6.66% | +100.1% |
| GLYC | GLYCOMIMETICS INC | $139,320,000 | -3.3% | 8,584,128 | 0.0% | 6.20% | +3.8% | |
| MRSN | MERSANA THERAPEUTICS INC | $128,435,000 | -4.0% | 8,144,267 | 0.0% | 5.71% | +3.1% | |
| EPZM | EPIZYME INC | $114,680,000 | +41.4% | 6,460,851 | 0.0% | 5.10% | +51.9% | |
| RYTM | RHYTHM PHARMACEUTICALS INC | $97,755,000 | -31.5% | 4,912,306 | 0.0% | 4.35% | -26.5% | |
| SENS | SENSEONICS HOLDINGS INC | $92,665,000 | +12.8% | 30,888,266 | 0.0% | 4.12% | +21.1% | |
| ARDX | ARDELYX INC | $71,122,000 | -23.5% | 14,083,582 | 0.0% | 3.16% | -17.8% | |
| AKAOQ | ACHAOGEN INC | $67,536,000 | +20.6% | 5,215,128 | 0.0% | 3.00% | +29.5% | |
| OBSV | OBSEVA SA | $61,896,000 | +38.3% | 4,586,563 | 0.0% | 2.75% | +48.5% | |
| AVEO | AVEO PHARMACEUTICALS INC | $47,452,000 | +3.9% | 16,362,694 | 0.0% | 2.11% | +11.6% | |
| ASNS | ARSANIS INC | $45,780,000 | +79.4% | 2,000,000 | 0.0% | 2.04% | +92.6% | |
| IMMU | IMMUNOMEDICS INC | $40,508,000 | -9.6% | 2,772,643 | 0.0% | 1.80% | -2.9% | |
| SYBX | Buy | SYNLOGIC INC | $39,672,000 | +7.1% | 4,229,410 | +10.7% | 1.76% | +15.0% |
| SBBP | STRONGBRIDGE BIOPHARMA PLC | $36,651,000 | +22.1% | 4,141,308 | 0.0% | 1.63% | +31.0% | |
| CMTA | CLEMENTIA PHARMACEUTICALS IN | $32,447,000 | -20.2% | 2,141,697 | 0.0% | 1.44% | -14.3% | |
| RARX | Buy | RA PHARMACEUTICALS INC | $29,171,000 | -1.8% | 5,493,636 | +57.2% | 1.30% | +5.5% |
| DERM | DERMIRA INC | $28,018,000 | -71.3% | 3,506,649 | 0.0% | 1.25% | -69.2% | |
| PTI | PROTEOSTASIS THERAPEUTICS INC | $26,395,000 | -18.5% | 5,556,778 | 0.0% | 1.17% | -12.5% | |
| GNCA | New | GENOCEA BIOSCIENCES INC | $26,250,000 | – | 25,000,000 | +100.0% | 1.17% | – |
| AUPH | AURINIA PHARMACEUTICALS INC | $24,956,000 | +14.6% | 4,808,483 | 0.0% | 1.11% | +23.1% | |
| VRNA | VERONA PHARMA PLCads | $24,393,000 | +68.5% | 1,219,674 | 0.0% | 1.08% | +80.8% | |
| LXRX | LEXICON PHARMACEUTICALS INC | $20,416,000 | -13.3% | 2,382,286 | 0.0% | 0.91% | -6.9% | |
| CTIC | New | CTI BIOPHARMA CORP | $14,625,000 | – | 3,750,000 | +100.0% | 0.65% | – |
| ERYP | ERYTECH PHARMA SAadr | $13,125,000 | -4.6% | 625,000 | 0.0% | 0.58% | +2.5% | |
| RIGL | RIGEL PHARMACEUTICALS INC | $11,481,000 | -8.8% | 3,243,150 | 0.0% | 0.51% | -1.9% | |
| DZSI | DASAN ZHONE SOLUTIONS INC | $10,940,000 | +23.5% | 956,255 | 0.0% | 0.49% | +32.7% | |
| ELGX | ENDOLOGIX INC | $10,534,000 | -20.9% | 2,490,204 | 0.0% | 0.47% | -15.0% | |
| NITE | NIGHTSTAR THERAPEUTICS PLCadr | $10,221,000 | +9.1% | 714,285 | 0.0% | 0.46% | +17.3% | |
| AFMD | Buy | AFFIMED NV | $9,507,000 | +88.0% | 5,138,888 | +32.1% | 0.42% | +102.4% |
| TRILLIUM THERAPEUTICS INC | $9,000,000 | -0.7% | 1,250,000 | 0.0% | 0.40% | +6.7% | ||
| TNTRQ | TINTRI INC | $8,983,000 | -66.5% | 5,253,358 | 0.0% | 0.40% | -64.0% | |
| TCON | Buy | TRACON PHARMACEUTICALS INC | $7,975,000 | -13.7% | 3,467,181 | +25.7% | 0.36% | -7.3% |
| RGLS | REGULUS THERAPEUTICS INC | $7,885,000 | -31.0% | 10,989,910 | 0.0% | 0.35% | -25.9% | |
| ARQL | ARQULE INC | $7,259,000 | +74.5% | 2,520,316 | 0.0% | 0.32% | +87.8% | |
| MDB | MONGODB INCcl a | $6,510,000 | +46.2% | 150,000 | 0.0% | 0.29% | +57.6% | |
| TRVN | TREVENA INC | $6,251,000 | +2.5% | 3,811,691 | 0.0% | 0.28% | +9.9% | |
| CSBR | CHAMPIONS ONCOLOGY INC | $5,688,000 | -6.2% | 1,562,500 | 0.0% | 0.25% | +0.8% | |
| AQ | AQUANTIA | $3,762,000 | +38.6% | 239,587 | 0.0% | 0.17% | +49.1% | |
| SNSS | SUNESIS PHARMACEUTICALS INC | $3,531,000 | -26.3% | 1,298,274 | 0.0% | 0.16% | -20.7% | |
| AKTX | AKARI THERAPEUTICS PLCadr | $823,000 | -58.0% | 452,167 | 0.0% | 0.04% | -54.3% | |
| AYTU | New | AYTU BIOSCIENCE INC | $29,000 | – | 44,908 | +100.0% | 0.00% | – |
| OREXQ | Exit | OREXIGEN THERAPEUTICS INC | $0 | – | -370,900 | -100.0% | -0.02% | – |
| ABIO | Exit | ARCA BIOPHARMA INC | $0 | – | -1,460,209 | -100.0% | -0.08% | – |
| CASC | Exit | CASCADIAN THERAPEUTICS INC | $0 | – | -9,064,575 | -100.0% | -1.39% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GLYCOMIMETICS INC | 39 | Q3 2023 | 7.6% |
| AURINIA PHARMACEUTICALS INC | 37 | Q3 2023 | 5.0% |
| CHAMPIONS ONCOLOGY INC | 33 | Q3 2023 | 1.2% |
| LEXICON PHARMACEUTICALS INC | 32 | Q3 2023 | 2.0% |
| ADAPTIMMUNE THERAPEUTICS PLC | 31 | Q3 2023 | 9.3% |
| TREVENA INC | 31 | Q3 2021 | 3.3% |
| AKARI THERAPEUTICS PLC | 31 | Q2 2023 | 0.3% |
| ARDELYX INC | 29 | Q3 2021 | 11.9% |
| RIGEL PHARMACEUTICALS INC | 29 | Q2 2020 | 0.6% |
| EPIZYME INC | 28 | Q1 2020 | 9.6% |
View NEA Management Company, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View NEA Management Company, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.